InvestorsHub Logo
icon url

JPG77

07/27/20 8:02 AM

#98614 RE: hemidriver #98613

I disagree. If the results are good, which most of us are expecting, especially given the recent announcements that Leronlimab patients had 63% less SAEs than the placebo patients, I think any short that's been paying attention will want to cover before Thursday.

This just means they will not have final trail results for us this week. Good news for the shorts.

icon url

Chasing Wealth

07/27/20 8:02 AM

#98615 RE: hemidriver #98613

FDA is continuing the trial unlike ‘many trials of other drugs so we are in great shape! NP doesn’t care about shorts anymore because he knows they have a winner. Hold on to your gold nuggets, no reason to sell.
icon url

JA2626

07/27/20 9:04 AM

#98637 RE: hemidriver #98613

I think Thursday will be hyuge...and if you believe this is the wrong PR tactics then send Cristins DeLeon at cytodyn an email message